James Ahlgren: Clinical Trials

2 trials sponsored by James Ahlgren, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Withdrawn 2

Follow James Ahlgren: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
paclitaxel, vinorelbine tartrate - Prostate Cancer
Phase 2WithdrawnJames Ahlgren1999-01-012017-07-13
Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer
edrecolomab, sargramostim - Colorectal Cancer
Phase 2WithdrawnJames Ahlgren1995-07-012017-07-13

Conditions studied

Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Rectal Neoplasms (1)

Interventions

Edrecolomab (1)  ·  Paclitaxel (1)  ·  Vinorelbine (1)  ·  sargramostim (1)

Countries

United States (2)

Top investigators

James D. Ahlgren, MD (2)